Abstract: The present invention relates to the use of an extract of Zingiber zerumbet, in particular of Zingiber zerumbet rhizome, or of a dermatological or cosmetic composition comprising such an extract, for combating dandruff and/or preventing the formation thereof.
Abstract: The invention relates to a new bacterial extract that can be used for protecting and/or treating sensitive skin and/or reactive, intolerant skin, particularly by means of targeted action on neurogenic inflammation of the skin. The invention also relates to cosmetic or dermatological compositions comprising such a bacterial extract as an active ingredient.
Abstract: This invention relates to a topical, cosmetic or dermatological composition, comprising a 1,3 diglyceride having the general formula (I), in which the radicals R1 and R2 represent, independently of one another, a C13 to C40 saturated and linear alkyl radical, and at least one cosmetic or dermatological excipient for a topical application on the skin. This invention also relates to such a composition, or a 1,3 diglyceride having the formula (I), for its use in protecting the skin, in countering the weakening of the skin barrier and in preventing or reducing the penetration of exogenous molecules into the skin following a weakening of the skin barrier.
Abstract: The present invention relates to a novel combination comprising an extract of watercress, an extract of Indian cress, and ATP, and to the use of said combination in the field of hair science, more particularly in the treatment or prevention of alopecia.
Abstract: The present invention relates to a combination including 4-[(1E,3S)-3-ethenyl-3,7-dimethylocta-1,6-dienyl]phenol and a Tahiti vanilla extract, and the use of said combination for combatting cutaneous ageing.
Type:
Application
Filed:
May 23, 2019
Publication date:
June 24, 2021
Applicant:
PIERRE FABRE DERMO-COSMETIQUE
Inventors:
Hélène DUPLAN, Daniel BACQUEVILLE, Stéphane POIGNY
Abstract: The present invention relates to the use of a cosmetic composition intended for dyeing keratin fibres, especially human hair, said cosmetic composition comprising as active principle a Gardenia extract.
Abstract: The present invention relates to a new combination comprising an extract of quinquina, an extract of Leontopodium alpinum and the manganese salt of L-pyrrolidonecarboxylic acid, and also to the use of said combination in the hair field, more particularly in the treatment or prevention of alopecia.
Type:
Application
Filed:
May 3, 2019
Publication date:
June 17, 2021
Applicant:
PIERRE FABRE DERMO-COSMETIQUE
Inventors:
Sylvie DAUNES-MARION, Marguerite LEVEQUE, Stéphane POIGNY, Anne MANDEAU
Abstract: The present invention relates to an extract of Lespedeza capitata Michx., for use in cosmetics and/or dermatology in the field of hair care and, more specifically, in the treatment and/or prevention of alopecia and/or seborrhea of the scalp.
Abstract: The present invention relates to a preparation obtained from an in vitro culture of undifferentiated cells of Mimosa pudica, as well as to the preparation method thereof; a cosmetic or dermatological composition comprising said preparation; and the uses thereof for the treatment of inflammatory skin conditions, as an antioxidant agent in the treatment of oxidative stress caused by environmental pollution, and as an anti-aging agent.
Abstract: The present invention relates to the cosmetic and dermatological use of a Copaifera extract in the treatment and/or prevention of alopecia and in the treatment of seborrhea.
Abstract: The invention relates to an extract of the aerial parts of Lawsonia inermis, as well as its preparation method and the extract that can be obtained by said method. The invention also relates to a cosmetic dye composition comprising such an extract. The invention finally concerns a cosmetic method for dying keratin fibers comprising the application of such a composition.
Type:
Application
Filed:
December 12, 2018
Publication date:
October 22, 2020
Applicant:
PIERRE FABRE DERMO-COSMETIQUE
Inventors:
Christel FIORINI PUYBARET, Philippe JOULIA, Laurent SUBRA
Abstract: This invention relates to a topical, cosmetic or dermatological composition, comprising a 1,3 diglyceride having the general formula (I), in which the radicals R1 and R2 represent, independently of one another, a C13 to C40 saturated and linear alkyl radical, and at least one cosmetic or dermatological excipient for a topical application on the skin. This invention also relates to such a composition, or a 1,3 diglyceride having the formula (I), for its use in protecting the skin, in countering the weakening of the skin barrier and in preventing or reducing the penetration of exogenous molecules into the skin following a weakening of the skin barrier.
Abstract: A device for transferring a sterile product from one container to another under aseptic conditions. The first container to initially contain the sterile product and equipped with an outlet. The outlet has a first pipe and two independently operable valves mounted in series thereon. The second container is equipped with an inlet having a second pipe and two independently operable valves mounted in series thereon. A removable hose to provide a sealed connection of the free end of the first pipe and the free end of the second pipe. A connector to connect the removable hose to a system for sterilizing the internal volume thereof. The system is operable when the removable hose connects the free end of the first pipe with the free end of the second pipe in a sealed manner.
Abstract: The present invention relates to the cosmetic and dermatological use of a Copaifera extract in the treatment and/or prevention of alopecia and in the treatment of seborrhea.
Abstract: The present invention relates to a novel combination comprising an extract of watercress, an extract of Indian cress, and ATP, and to the use of said combination in the field of hair science, more particularly in the treatment or prevention of alopecia.
Abstract: The present invention relates to the use of 6-O-(C8-C20 alkyl ester) of 1-O-(C1-C6 alkyl)-?-D-glucoside and in particular 6-O-lauroyl of 1-O-n-butyl-?-D-glucoside as an agent for protecting the skin and/or mucous membranes. The invention relates specifically to a cosmetic, dermatological and/or pharmaceutical composition, intended for topical use, which can be used for skin care and/or treatment.
Abstract: The present invention relates to a novel use of a bacterial secretome in the field of the treatment of skin lesions and more particularly of wound healing. The invention also relates to cosmetic or dermatological compositions comprising such a bacterial secretome as active agent.
Type:
Application
Filed:
April 6, 2018
Publication date:
January 30, 2020
Applicant:
PIERRE FABRE DERMO-COSMETIQUE
Inventors:
Nathalie CASTEX-RIZZI, Marie Florence GALLIANO, Hélène HERNANDEZ-PIGEON
Abstract: The invention relates to a method for producing an extract of a matrix of vegetable origin, particularly a plant, characterised in that the matrix of vegetable origin undergoes a mechanical treatment consisting in extruding the matrix of vegetable origin in an extruder, in association or not with a heat treatment, in the presence of an aqueous solution containing at least one hydrotrope agent, particularly at a concentration at least equal to the minimum hydrotrope concentration thereof, followed by an operation of recovering the extract.
Abstract: The present invention relates to the novel combination of pongamia oil and 4-t-butylcyclohexanol, and to the uses thereof in the fields of cosmetics and dermatology to combat redness. More specifically, the present invention relates to the cosmetic use of a composition comprising said combination to combat rosacea.
Abstract: A method for high temperature sterilization of an emulsion, in particular a dermocosmetic preparation. The method includes the steps of gradually pre-heating, performing ultra-high temperature sterilization and gradually cooling the emulsion. The emulsion is heated up to a pre-heating temperature, which is the temperature of the emulsion at the stability limit. Ultra-high temperature sterilization is performed by infusion of the pre-heated emulsion by heating the emulsion up to a sterilization temperature, maintaining the emulsion at the sterilization temperature, and cooling the emulsion under a vacuum at an end-of-sterilization temperature. The emulsion is gradually cooled with agitation to a storage temperature.